The increased expression of Multidrug-Resistance Protein 1 (MDR1) [P-glycoprotein (PgP) efflux pump] in tumor cells, which is an important ABC transporter, increases the extracellular excretion of the drugs, resulting in a decrease in the effectiveness of PARP inhibitors [68]. The gene discussed is PARP1; the disease is neoplasm.